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and Andre Kalil7Abstract
Background: Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis (AFP) in the
post-poliomyelitis eradication era. This is the first study done to identify the epidemiology, clinical features, and
outcome of GBS in Iraqi children over 15 years.
Methods: The surveillance database about AFP cases < 15 years reported during January 1997-December 2011
was used.
Results: GBS represented 52.5% of AFP cases, with an incidence of 1.33 case/100,000 population < 15 years/year.
There was a higher incidence in the Southern provinces, age group 1–4 years, males, and outside the capital
city of province, with no significant seasonal variations (p = .22). Survival probability after the 1 year of onset for
those with respiratory muscle involvement was .76 (95% CI: .60-.86), versus .97 (95% Cl: .96-.98) for those who
did not develop it (p < .001); and .97 (95% CI: .96-.98) for those living inside the capital city, versus .94 (.93-.95)
for those living outside (p = .001). Cumulative incidence of residual paralysis for patients living inside the capital
city was .21 (95% CI: .18-.24), versus .27 (95% CI: .25-.29) for those living outside (p < .001).
Conclusions: The incidence, age and gender distribution, and seasonality of GBS among Iraqi children is similar
to those reported from other previous studies. It is the most important cause of AFP, especially in those
between the age of 1 to 4 years living in rural areas.Background
Guillain-Barré syndrome (GBS) is mostly an acute inflam-
matory demyelinating ascending polyradiculoneuropathy
[1-3]. Flu-like illness or gastroenteritis precedes the onset
of paralysis by 6 weeks in about two-thirds of patients [3].
The culprit infectious agent often remains unrecognized,
but Compylobacter jejuni Mycoplasma pneumonia, and
cytomegalovirus are commonly reported triggering patho-
gens. Molecular mimicry between structural components
of both pathogens and myelin sheath of peripheral nerves,
with subsequent cross-reaction of antibodies with the lat-
ter, is a commonly proposed hypothesis for the pathogen-
esis of disease [3-6].* Correspondence: jagar.jasem@osumc.edu
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reproduction in any medium, provided the orWorldwide, GBS is considered the most common cause
of acute flaccid paralysis in the post-poliomyelitis eradica-
tion era [5-14]. It affects people in various geographical lo-
cations and virtually all age groups [15]. Similar studies
about the epidemiology and clinical features of GBS yield
a wide range of minor to major differences [4,10,15-18].
Information about the epidemiology of the disease can
give insights into the changing patterns of the disease inci-
dence following exposure to new potential provoking fac-
tors [16]. Measuring the outcome of the disease in terms
of mortality and morbidity can help direct attention to-
wards modifying the risk factors of adverse disease out-
comes. This is the first study done to identify the
epidemiology, clinical features, and outcome of GBS in
Iraqi children over 15 years of study.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Causes of acute flaccid paralysis in Iraqi
children, 1997-2011
Cause Number (%)
Guillain-Barré syndrome 2611 (52.5)
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The surveillance database about acute flaccid paralysis
(AFP) cases under the age of 15 reported from Iraq dur-
ing January 1997 to December 2011 was used in the
current study. AFP surveillance is an essential strategy of
the Polio Eradication Initiative adopted by the World
Health Organization (WHO) in 1988. AFP is defined as
“any child under 15 years of age with acute flaccid par-
alysis (including GBS) or any person of any age with
paralytic illness if polio is suspected”. AFP information is
routinely included in the weekly and monthly reporting
system from the Preventive Health Department (PHD)
in the Directorate General of Health (DGoH) of every
Iraqi province, even if there is no reported case (routine
surveillance “zero-reporting”). Notifications are done via
mailing the standard communicable notification forms
designed by the Iraqi Ministry of Health to the Commu-
nicable Disease Control Unit (CDCU) of the regional
PHD. Active surveillance for the suspected cases of AFP
is ideally done within 48 hours via a designed investigating
team from the CDCU visiting the reporting sources (hos-
pitals, rehabilitation centers, or private clinics). Case in-
vestigation is done using a WHO-standardized form [19].
Two stool specimens are collected from each sus-
pected case with an interval of 24–48 hours between
collections, given that no more than two months have
elapsed since the onset of paralysis. Following collection,
the specimens are kept in a cold box to be sent for the
National Polio Laboratory in Baghdad. At least 60 days
after the onset of paralysis, all surviving patients are re-
examined by an expert committee for residual paralysis.
The diagnosis of GBS was made based on clinical evalu-
ation and cytochemical analysis of the cerebrospinal
fluid retrieved via conducting a lumbar puncture test of
the suspected cases.
There is no clear classification for “urban” and “rural”
areas in Iraq. Hence, the most approximate encounter
for that fact is via dividing each Province into areas in-
side and outside the Capital City of each; referring to
more urban and more rural areas, respectively.
The study was approved by the Ethical Committee of
the Faculty of Medical Sciences/University of Duhok,
Duhok, Iraq and the Institutional Review Board (IRB) of
the University of Nebraska Medical Center, Omaha,
Nebraska, USA. The statistical analysis was done using
SPSS 18 for Windows/MAC, (PASW® Statistics Grad-
Pack 18). Statistical analyses included: Chi-square test,
univariate Kaplan-Meier survival analysis and stratified
log-rank tests. All tests were two sided with .05 level of
significance.
Results
A total number of 5027 cases were reported from Iraq
between January 1997 and December 2011. Out of these,53 cases were excluded as they were not AFP (nutri-
tional deficiencies and skeletal diseases). A total of 4974
cases of AFP were used in the final analysis. GBS repre-
sented more than half of the reported cases (N = 2611,
52.5%) (Table 1), corresponding to an annual incidence
of 1.33 case/100,000 population under the age of 15 years
(95% CI: .97-1.68). There was a higher incidence in the
Southern provinces compared to the Central and North-
ern ones (Figure 1). The vast majority of cases belonged
to the age group 1–4 years old (Figure 2). Male–female
ratio was 1.35:1. About 65% of cases occurred outside
the capital city of province of more rural social charac-
teristics. Cases were reported throughout the year with
the highest number being in January (261) and the low-
est in August (173) (Figure 3). This monthly variation
was not statistically significant (p = .22).
Fever was observed in 1358 (55.4%) of cases, and pro-
gression of paralysis to the maximum within 4 days of
onset occurred in 2450 (97.1%) of cases. At least 60 days
from the onset of paralysis, 619 (24.6%) of cases had re-
sidual paralysis and 118 (4.8%) others died (Table 2).
The probability of survival after the 1 year of onset for
those with respiratory muscle involvement was .76 (95%
CI: .60-.86), versus .97 (95% Cl: .96-.98) for those who
did not develop respiratory muscle weakness (p < .001)
(Figure 4). Kaplan-Meier analysis of household location,
gender, and age showed that only household location
was significantly associated with the decreased probabil-
ity of survival. The cumulative survival for patients living
inside the capital city of province was .97 (95% CI: .96-.98),
versus .94 (.93-.95) for those living outside the capital city
of province (p = .001) (Figure 5). This effect was eliminated
when stratified log-rank test was performed for both
respiratory muscle paralysis and household location
(p = .21). Likewise, Kaplan-Meier analysis of house-
hold location, gender, and age showed that both
household location and age were significantly associ-
ated with increased cumulative incidence of residual par-
alysis. The cumulative incidence of residual weakness
Figure 1 Incidence of Guillain-Barré syndrome per province, Iraq, 1997–2011.
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below the age of 5 years and .35 (.29-.41) for those above
the age of 5 years (p = .001) (Figure 6). The cumulative in-
cidence of residual paralysis for patients living inside the
capital city of province was .21 (95% CI: .18-.24), versus .27
(95% CI: .25-.29) for those living outside the capital city of
province (p < .001) (Figure 7). This effect was maintained
when stratified log-rank test was performed for both age
and household location (p = .001).
Discussion
The annual incidence among Iraqi children was 1.33/
100,000 population under the age of 15 years. This rate
is at the upper limit of the reported international range
of .34-1.34 cases/100,000/year among children aged <15 years
[16]. Figures as high as 5 cases/100,000/year have been
reported from some districts in Bangladesh [7].Figure 2 Number of cases with Guillain-Barré syndrome per age grouUnlike other autoimmune diseases, males are typically
affected more than females [10,16,20,21]. However, male
predilection is found in other immune-mediated periph-
eral neuropathies like chronic inflammatory demyelinat-
ing polyneuropathy, multifocal motor neuropathy and
Miller-Fisher syndrome [4]. Our study showed a male–
female ratio of 1.3:1. Individual studies report ratios of
1.5 to 2.7 males to 1 female [20]. However, estimated
662 children reported in different studies have shown a
male–female ratio of 1.3:1. Likewise, a total of 1607 pa-
tients of all ages reported in different studies have shown
a similar ratio of 1.3:1 [20]. Pooled data about the cases
of GBS in Latin America showed the exact same ratio
[21]. This indicates that the higher preponderance of
males in individual studies is likely to be the product
of the confounding effect of sample size (Simpson’s
paradox) [20].p, Iraq, 1997–2011.
Figure 3 Number of cases with Guillain-Barré syndrome per month, Iraq, 1997–2011.
Jasem et al. BMC Neurology 2013, 13:195 Page 4 of 8
http://www.biomedcentral.com/1471-2377/13/195In accordance with other reports, children 1–4 years
old were the most commonly affected age group with
GBS in our study [9,10,22,23]. This is believed to be due
to their relatively high susceptibility to infections in this
age group and the increased susceptibility to the young
myelinated peripheral nerves to demyelination [22,23].
Southern provinces have a statistically significant higher
incidence of GBS compared to both Central and Northern
ones. Although no specific reason was found, geographic
variation in the incidence of disease in Iraq may be due to
differences in the infection rates and climate among the
different regions [7,9].Table 2 Selected clinical characteristics of cases with
Guillain-Barré syndrome, Iraq, 1997-2011
Features Cases (%)
Fever at the onset of paralysis 2449 (93.8)
Yes 1358 (55.4)
No 1091 (44.5)
Progression to the maximum paralysis









Survival at least 60 days from onset 2461 (94.2)
Alive 2343 (95.2)
Dead 118 (4.8)Many studies have addressed the seasonality in the in-
cidence of GBS, [9,15,16,24,25] only a few demonstrated
a significant seasonal trend [18,24,26,27]. The lack of
clear seasonal association may be due to the fact that
the respiratory and enteric infections that precede GBS
have opposite seasonal patterns [17]. The higher number
of cases reported in winter and spring in our study is
similar to reports from Southern Iran and Kuwait [18,28].
In general, different countries have different clustering
patterns of cases, which might reflect the heterogeneity of
the infectious agents that trigger the disease. The same
reason may explain the higher number of cases reported
outside the capital city of provinces, dominated by rural
areas.
Although not classically attributed to the disease process
of GBS [9,29], fever at the onset of paralysis is reported
from previous studies and may be attributed to the effect
of the triggering infectious disease [9,21,30]. Our study re-
vealed that 55.4% of cases had fever at the onset of paraly-
sis. As it might be expected from a study that is primarily
concerned about AFP surveillance as a sensitive measure
to detect cases of poliomyelitis, specific details about the
progression pattern of weakness, sensory involvement,
and dysautonomia in patients with GBS were not recorded
in the study.
Although information about respiratory muscle in-
volvement were only recorded for 1166 (44.7%) of pa-
tients, cumulative survival was significantly lower in
those with respiratory muscle involvement. Likewise, the
cumulative survival was significantly lower among those
living outside the capital city of province. However, the
latter association was insignificant when stratified by re-
spiratory muscle involvement. This indicates that house-
hold location is not an independent cause of death per
Figure 4 Cumulative survival of cases with Guillain-Barré syndrome based on history of respiratory muscle paralysis, Iraq, 1997–2011.
Figure 5 Cumulative survival of cases with Guillain-Barré syndrome based on their household location within the province,
Iraq, 1997–2011.
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Figure 6 Cumulative incidence of residual paralysis among cases with Guillain-Barré syndrome, Iraq, 1997–2011.
Figure 7 Cumulative incidence of residual weakness among cases with Guillain-Barré syndrome based on their household location
within the province, Iraq, 1997–2011.
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which plays a “mediating” effect. Furthermore, the as-
sociation between household location and respiratory
paralysis was insignificant too (p = .12), indicating that
although respiratory paralysis occurs equally among those
living inside and outside the capital city of province; the
latter group are more likely die from it. This finding may
be due to one or more of: differences of the inciting fac-
tors, delayed diagnosis in the rural areas, and inaccessibil-
ity to the required intensive care in those areas.
Respiratory intensive care units do not exist in the vast
majority of hospitals serving the rural communities in
Iraq.
The risk of residual paralysis was higher among chil-
dren above the age of 5 years. In general, the prognosis
of GBS is shown to be better among younger age groups,
although comparisons were generally made with adults
[31-33]. In the largest prospective study by Korinthenberg
et al., 96% of children were either asymptomatic or had
minor symptoms at the end of the 288-day observation
period [34]. This might reflect poorer axonal outgrowth
and regeneration and less effective remyelinization process
with increasing age [32]. Again, lower quality of and
access to health care might underlie the increased risk
of residual paralysis among cases residing outside the
capital city of province.
The current study is the first to be done in Iraq involv-
ing analysis of nation-wide data over 15 years of study. It
presents information about the overall incidence of dis-
ease, as well as the differences in disease incidence with
time, age, gender, season, province of residence, and
household location within the province of residence. It
also provides information about the case-fatality rate of
the disease and the likelihood of developing residual
weakness following the resolution of acute disease, with
emphasis on gender, age, and household location differ-
ences in those adverse outcomes. The sensitivity of AFP
investigation was 2.5 cases/100,000 population below the
age of 15 (above the WHO-recommended cut-off level
of 1/100,000) and completeness of reporting was 96%
(above the above the WHO-recommended cut-off level
of 80%). These two performance indicators imply that
the vast majority of GBS cases among children below15
years were effectively detected and recorded in the
current database. However, since the data were collected
for the purpose of acute flaccid surveillance as a strategy
for detecting cases of poliomyelitis, the study provides
limited information about the clinical features and sub-
types of disease. Future studies are needed to at least
identify the main 4 main subtypes of GBS, including: acute
inflammatory demyelinating polyradiculoneuropathy (AIDP),
acute motor axonal neuropathy (AMAN) and acute motor
and sensory axonal neuropathy (AMSAN), and Miller Fisher
syndrome [16]. Likewise, no data were available about thetreatment modalities used for treating GBS cases. However,
IVIG therapy remains largely unavailable in Iraq. Informa-
tion about the history of preceding respiratory and
gastrointestinal infection needs to be documented in
future studies.
Conclusions
The incidence, age and gender distribution, and season-
ality of GBS among Iraqi children is similar to those re-
ported from other previous studies. It is the most important
cause of AFP, especially in those between the age of 1 to
4 years living in rural areas.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JJ has made substantial contributions to design of the study, data analysis,
and writing and submitting the manuscript. KM, AN, YK, SA, and FH have
contributed in data acquisition and manuscript revision. MI and AK have
supervised study design and data analysis, as well as critically revised the
manuscript. All authors have read and approved the final manuscript.
Author details
1School of Medicine/ Faculty of Medical Sciences/ University of Duhok,
Nakhoshkhana Street, Duhok, Kurdistan Region, Iraq. 2Internal Medicine, Ohio
State University, Columbus, Ohio, USA. 3Directorate of Preventive Health
Affairs, Directorate General of Health, Mazi Street, Duhok, Kurdistan Region,
Iraq. 4National Communicable Disease Control, Ministry of Health, Bab Al
Mudam Area, Baghdad, Iraq. 5AFP Surveillance Laboratory, Ministry of Health,
Bab Al Mudam Area, Baghdad, Iraq. 6College of Public Health, University of
Nebraska Medical Center, Omaha, Nebraska, USA. 7Division of Infectious
Diseases/Department of Internal Medicine, University of Nebraska Medical
Center, Omaha, Nebraska, USA.
Received: 19 July 2013 Accepted: 5 December 2013
Published: 10 December 2013
References
1. Beherman R, Kliegman R, Jenson H: Nelson’s Textbook of Pediatrics.
Philadelphia: Saunders; 2003.
2. Kasper D, Braunwals E, Hauser S, Longo D, Jameson L, Antony F: Harrison’s
principles of internal medicine. New York: McGraw-Hill Professional; 2005.
3. Hughes RA, Cornblath DR: Guillain-Barre syndrome. Lancet 2005,
366(9497):1653–1666.
4. Kuwabara S: Guillain-Barre syndrome: epidemiology, pathophysiology
and management. Drugs 2004, 64(6):597–610.
5. Oomes PG, Jacobs BC, Hazenberg MP, Banffer JR, van der Meche FG:
Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre
syndrome: evidence of molecular mimicry. Ann Neurol 1995, 38(2):170–175.
6. Sladky JT: Guillain-Barre syndrome in children. J Child Neurol 2004,
19(3):191–200.
7. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P,
Diorditsa S, Luby SP, Talukder KA, Endtz HP: Axonal variant of Guillain-Barre
syndrome associated with Campylobacter infection in Bangladesh.
Neurology 2010, 74(7):581–587.
8. Lam RM, Tsang TH, Chan KY, Lau YL, Lim WL, Lam TH, Leung NK, National
Committee for the Certification of Wild Poliovirus Eradication: Surveillance
of acute flaccid paralysis in Hong Kong: 1997 to 2002. Hong Kong Med J
2005, 11(3):164–173.
9. Landaverde JM, Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL,
Ruiz-Matus C: Guillain-Barre syndrome in children aged <15 years in
Latin America and the Caribbean: baseline rates in the context of
the influenza A (H1N1) pandemic. J Infect Dis 2010, 201(5):746–750.
10. Molinero MR, Varon D, Holden KR, Sladky JT, Molina IB, Cleaves F:
Epidemiology of childhood Guillain-Barre syndrome as a cause of acute
flaccid paralysis in Honduras: 1989–1999. J Child Neurol 2003, 18(11):741–747.
Jasem et al. BMC Neurology 2013, 13:195 Page 8 of 8
http://www.biomedcentral.com/1471-2377/13/19511. Morris AM, Elliott EJ, D’Souza RM, Antony J, Kennett M, Longbottom H:
Acute flaccid paralysis in Australian children. J Paediatr Child Health 2003,
39(1):22–26.
12. Oostvogel PM, Spaendonck MA, Hirasing RA, van Loon AM: Surveillance of
acute flaccid paralysis in The Netherlands, 1992–94. Bull World Health
Organ 1998, 76(1):55–62.
13. Poorolajal J, Ghasemi S, Farahani LN, Hosseini AS, Bathaei SJ, Zahiri A:
Evaluation of acute flaccid paralysis in hamadan, iran from 2002 to 2009.
Epidemiol Health 2011, 33:e2011011.
14. Saraswathy TS, Zahrin HN, Apandi MY, Kurup D, Rohani J, Zainah S,
Khairullah NS: Acute flaccid paralysis surveillance: looking beyond the
global poliomyelitis eradication initiative. Southeast Asian J Trop Med
Public Health 2008, 39(6):1033–1039.
15. Chroni E, Papapetropoulos S, Gioldasis G, Ellul J, Diamadopoulos N,
Papapetropoulos T: Guillain-Barre syndrome in Greece: seasonality
and other clinico-epidemiological features. Eur J Neurol 2004,
11(6):383–388.
16. McGrogan A, Madle GC, Seaman HE, de Vries CS: The epidemiology of
Guillain-Barre syndrome worldwide. A systematic literature review.
Neuroepidemiology 2009, 32(2):150–163.
17. Hughes RA, Rees JH: Clinical and epidemiologic features of Guillain-Barre
syndrome. J Infect Dis 1997, 176(Suppl 2):S92–S98.
18. Borhani Haghighi A, Banihashemi MA, Zamiri N, Sabayan B, Heydari ST,
Safari A, Lankarani KB: Seasonal variation of Guillain-Barre syndrome
admission in a large tertiary referral center in southern Iran: a 10 year
analysis. Acta Neurol Taiwan 2012, 21(2):60–63.
19. World Health Organization, Iraqi Ministry of Health: Acute Flaccid Paralysis
Field Manual. Baghdad: WHO & Iraqi MOH; 2009.
20. Ammache Z, Afifi AK, Brown CK, Kimura J: Childhood Guillain-Barre
syndrome: clinical and electrophysiologic features predictive of outcome.
J Child Neurol 2001, 16(7):477–483.
21. Olive JM, Castillo C, Castro RG, de Quadros CA: Epidemiologic study of
Guillain-Barre syndrome in children <15 years of age in Latin America.
J Infect Dis 1997, 175(Suppl 1):S160–S164.
22. Koul R, Al-Futaisi A, Chacko A, Fazalullah M, Nabhani SA, Al-Awaidy S,
Al-Busaidy S, Al-Mahrooqi S: Clinical characteristics of childhood
guillain-barre syndrome. Oman Med J 2008, 23(3):158–161.
23. Rantala H, Cherry JD, Shields WD, Uhari M: Epidemiology of Guillain-Barre
syndrome in children: relationship of oral polio vaccine administration
to occurrence. J Pediatr 1994, 124(2):220–223.
24. Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A,
Rodriguez P, Garcia Briseno A, Cordero LM, Garcia Perea L, Perez JC, Ribera
M, Aldama PC, Guiterrez GD, Sarnat LF, Garcia MR, Veitch J, Fitzgerald C,
Cornblath DR, Rodriguez Pinto M, Griffin JW, Willison HJ, Asbury AK,
McKhann GM: Patterns of Guillain-Barre syndrome in children: results
from a Mexican population. Neurology 2007, 69(17):1665–1671.
25. Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meche FG:
Mild forms of Guillain-Barre syndrome in an epidemiologic survey in The
Netherlands. Neurology 2000, 54(3):620–625.
26. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J: Epidemiological features of
Guillain-Barre syndrome in Sweden, 1978–93. J Neurol Neurosurg Psychiatry
1997, 62(5):447–453.
27. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST: Guillain-Barre syndrome in
Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997,
63(4):494–500.
28. Ismail EA, Shabani IS, Badawi M, Sanaa H, Madi S, Al-Tawari A, Nadi H, Zaki M,
Al-saleh Q: An epidemiologic, clinical, and therapeutic study of childhood
Guillain-Barre syndrome in Kuwait: is it related to the oral polio vaccine?
J Child Neurol 1998, 13(10):488–492.
29. van Doorn PA, Ruts L, Jacobs BC: Clinical features, pathogenesis, and
treatment of Guillain-Barre syndrome. Lancet Neurol 2008, 7(10):939–950.
30. Koga M, Yuki N, Hirata K: Antecedent symptoms in Guillain-Barre syndrome:
an important indicator for clinical and serological subgroups. Acta Neurol
Scand 2001, 103(5):278–287.
31. Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, Dhawan B: Outcome
in childhood Guillain-Barre syndrome. Indian J Pediatr 2009, 76(8):795–799.
32. Anonymous: The prognosis and main prognostic indicators of guillain-barre
syndrome. A multicentre prospective study of 297 patients. The Italian
guillain-barre study group. Brain 1996, 119(Pt 6):2053–2061. Pt 6.33. Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC:
Early recognition of poor prognosis in Guillain-Barre syndrome.
Neurology 2011, 76(11):968–975.
34. Korinthenberg R, Schessl J, Kirschner J: Clinical presentation and course of
childhood Guillain-Barre syndrome: a prospective multicentre study.
Neuropediatrics 2007, 38(1):10.
doi:10.1186/1471-2377-13-195
Cite this article as: Jasem et al.: Guillain-Barré syndrome as a cause of
acute flaccid paralysis in Iraqi children: a result of 15 years of nation-wide
study. BMC Neurology 2013 13:195.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
